TB-500

Engineered for serious research, TB-500 is one of the most sought-after regenerative peptides in the Canadian market: a synthetic fragment of Thymosin Beta-4 studied for its remarkable influence over actin dynamics, cell migration, angiogenesis, and tissue resilience.¹ When you source TB-500 Canada-wide from Helixx Online, you get lab-tested Canadian peptides backed by transparent third-party analysis and fast domestic dispatch, with the quality and consistency demanding research protocols require.

What Is TB-500?

TB-500 is a synthetic, acetylated seven-amino-acid peptide (Ac-LKKTETQ) that corresponds to the actin-binding domain (residues 17 to 23) of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid, roughly 4.9 kDa peptide found in nearly every cell type. Tβ4 is best known as a G-actin-sequestering peptide, meaning it binds monomeric actin and helps govern the assembly of the cellular cytoskeleton. TB-500 reproduces the short functional motif thought to drive many of these actin-regulating effects, which is why it has become a popular subject of study in cell-motility, wound-healing, and tissue-repair research. It belongs to the regenerative/healing peptide class and is offered strictly as a research chemical. It is not an approved drug. Researchers often study it alongside related repair compounds such as BPC-157 or the combined GLO (TB-500 + BPC-157 + Copper GHk Peptide Blend).

How TB Works

The core mechanism of TB-500 is the regulation of actin cytoskeletal dynamics. Its LKKTET motif binds monomeric G-actin with high affinity (Kd of roughly 0.5 to 2 µM), maintaining an intracellular pool of unpolymerized actin and modulating its polymerization into filamentous F-actin. This regulation enhances cell motility, cell-matrix interactions, and the matrix remodelling that underpins wound healing and tissue repair. Beyond direct actin sequestration, Thymosin Beta-4 forms a functional complex with PINCH and integrin-linked kinase (ILK), activating the survival kinase Akt/PKB to promote cell survival and migration, an effect demonstrated in cardiomyocytes and endothelial cells.¹ It also behaves as an anti-inflammatory agent, reducing inflammatory mediators and infiltrating cells in part by interfering with NF-κB signalling and modulating the MMP/TIMP balance, alongside anti-apoptotic and antioxidant activity.³ Together, these pleiotropic actions (regeneration, angiogenesis, anti-inflammation, and anti-fibrosis) form the scientific basis for its study. Bear in mind that nearly all published data describe full-length Thymosin Beta-4 (studied clinically as RGN-259) rather than the TB-500 fragment specifically.

What the Research Shows

• Cardiac survival and migration. In a foundational study, Tβ4 promoted myocardial and endothelial cell migration, formed a complex with PINCH and ILK to activate Akt, and, after coronary artery ligation in mice, improved early myocyte survival and cardiac function, defining the ILK/Akt survival-and-migration mechanism.¹
• Angiogenesis and neovascularization. Tβ4 was shown to be essential for coronary vessel development and to stimulate outgrowth from quiescent adult epicardial explants, driving differentiation into endothelial and smooth muscle cells and inducing new blood-vessel formation in the adult heart.²
• Wound healing and anti-inflammation. Experimental ophthalmic work found Tβ4 promotes corneal re-epithelialization, decreases inflammation, and modulates the MMP/TIMP balance, an effect hypothesized to work by interfering with NF-κB inflammatory signalling.³

Researchers comparing regenerative and secretagogue approaches frequently study TB-500 next to peptides such as CJC-1295 and Ipamorelin to explore complementary recovery pathways.

Chemical Properties

Research Protocols & Handling

All TB-500 supplied by Helixx Online is intended for laboratory, research, and educational use only. It is not for human consumption and not for veterinary use. Lyophilized peptide should be stored cool, dry, and protected from light; for long-term stability keep the sealed vial refrigerated or frozen. Reconstitution is typically performed with bacteriostatic or sterile water, after which the solution should be refrigerated and used within a limited window to preserve integrity. Because peptides are sensitive to repeated temperature cycling, minimize freeze-thaw cycles and handle under clean conditions. As with any research chemical, aliquoting and careful documentation of concentration and handling support reproducible experimental work.

Potential Side Effects & Safety

References

Peer-reviewed and authoritative sources cited above. Helixx supplies research materials for laboratory and educational use only; citations are provided for independent verification, not as medical guidance.

1. Bock-Marquette I, Saxena A, White MD, DiMaio JM, Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-472. PMID: 15565145.
2. Smart N, Risebro CA, Melville AAD, Moses K, Schwartz RJ, Chien KR, Riley PR. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature. 2007;445(7124):177-182. PMID: 17108969.
3. Sosne G, Qiu P, Kurpakus-Wheater M. Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent. Clin Ophthalmol. 2007;1(3):201-207. PMID: 19668473.